Literature DB >> 12598741

Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines.

Chris Wing-Cheung Lee1, Kwok-Fai Lau, Christopher C J Miller, Pang-Chui Shaw.   

Abstract

To study further the role of glycogen synthase kinase-3beta on tau phosphorylation, glycogen synthase kinase-3beta and tau expression vectors were co-transfected into CHO-K1, COS-7 and SH-SY5Y cell. Tau phosphorylation was assessed by phosphorylation-dependent antibodies AT-8, AT-180, AT-270 and PHF-1. The AT-270 and AT-8 epitopes were consistently phosphorylated by glycogen synthase kinase-3beta in the three cell lines. Phosphorylation on AT-180 epitope was significant in CHO-K1 and SH-SY5Y cells while PHF-1 epitope was hyper-phosphorylated only in SH-SY5Y cells. We also found that lithium induces phosphorylation of the serine 9 residue of glycogen synthase kinase-3beta together with inhibition of tau phosphorylation on PHF-1 epitope in all the three cell lines. This suggests a novel mechanism whereby lithium-mediated inhibition of GSK-3beta activity influences tau phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598741     DOI: 10.1097/00001756-200302100-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

1.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

2.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.

Authors:  Michael Demars; Yuan-Shih Hu; Archana Gadadhar; Orly Lazarov
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

3.  Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models.

Authors:  Zhefan Stephen Chen; Li Li; Shaohong Peng; Francis M Chen; Qian Zhang; Ying An; Xiao Lin; Wen Li; Alex Chun Koon; Ting-Fung Chan; Kwok-Fai Lau; Jacky Chi Ki Ngo; Wing Tak Wong; Kin Ming Kwan; Ho Yin Edwin Chan
Journal:  EMBO Rep       Date:  2018-07-19       Impact factor: 8.807

Review 4.  RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours.

Authors:  Fei Xu; Lixin Na; Yanfei Li; Linjun Chen
Journal:  Cell Biosci       Date:  2020-04-01       Impact factor: 7.133

5.  Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.

Authors:  J Chu; E Lauretti; D Praticò
Journal:  Mol Psychiatry       Date:  2017-01-31       Impact factor: 15.992

6.  Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats.

Authors:  Peng Liu; Li-Bo Zou; Li-Hua Wang; Qing Jiao; Tian-Yan Chi; Xue-Fei Ji; Ge Jin
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

Review 7.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 8.  Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Authors:  I Kadiu; J G Glanzer; J Kipnis; H E Gendelman; M P Thomas
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

9.  Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice.

Authors:  Martina Wiedau-Pazos; Eugene Wong; Esther Solomon; Maricela Alarcon; Daniel H Geschwind
Journal:  Neurobiol Aging       Date:  2007-07-02       Impact factor: 4.673

Review 10.  Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease.

Authors:  Yasuko Kitagishi; Atsuko Nakanishi; Yasunori Ogura; Satoru Matsuda
Journal:  Alzheimers Res Ther       Date:  2014-06-20       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.